These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32205075)
1. Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study. Moosaie F; Davatgari RM; Firouzabadi FD; Esteghamati S; Deravi N; Meysamie A; Khaloo P; Nakhjavani M; Esteghamati A Can J Diabetes; 2020 Jul; 44(5):414-421. PubMed ID: 32205075 [TBL] [Abstract][Full Text] [Related]
2. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes. Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732 [TBL] [Abstract][Full Text] [Related]
3. Relevance of the serum apolipoprotein ratio to diabetic retinopathy. Deguchi Y; Maeno T; Saishin Y; Hori Y; Shiba T; Takahashi M Jpn J Ophthalmol; 2011 Mar; 55(2):128-31. PubMed ID: 21400057 [TBL] [Abstract][Full Text] [Related]
4. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Serum Apolipoproteins and Traditional Lipids in Eyes with Diabetic Retinopathy in Indian Population: A Case Series. Prakash G; Agrawal R; Satsangi SK; Prakash S Middle East Afr J Ophthalmol; 2016; 23(2):212-4. PubMed ID: 27162455 [TBL] [Abstract][Full Text] [Related]
6. Associations between serum apolipoproteins, urinary albumin excretion rate, estimated glomerular filtration rate, and diabetic retinopathy in individuals with type 2 diabetes. Chung JO; Park SY; Cho DH; Chung DJ; Chung MY Medicine (Baltimore); 2019 May; 98(20):e15703. PubMed ID: 31096517 [TBL] [Abstract][Full Text] [Related]
7. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device. Zeng Y; Cao D; Yang D; Zhuang X; Yu H; Hu Y; Zhang Y; Yang C; He M; Zhang L Doc Ophthalmol; 2020 Jun; 140(3):211-220. PubMed ID: 31720980 [TBL] [Abstract][Full Text] [Related]
8. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients. Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy. Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285 [TBL] [Abstract][Full Text] [Related]
10. Association Between Serum Lipoprotein(a) and Diabetic Retinopathy in Han Chinese Patients With Type 2 Diabetes. Tu WJ; Liu H; Liu Q; Cao JL; Guo M J Clin Endocrinol Metab; 2017 Jul; 102(7):2525-2532. PubMed ID: 28472352 [TBL] [Abstract][Full Text] [Related]
11. The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes. Kadoglou NP; Fotiadis G; Athanasiadou Z; Vitta I; Lampropoulos S; Vrabas IS Endocrine; 2012 Dec; 42(3):561-9. PubMed ID: 22407494 [TBL] [Abstract][Full Text] [Related]
12. Analyses of serum lipoprotein(a) and the relation to phenotypes and genotypes of apolipoprotein(a) in type 2 diabetic patients with retinopathy. Suehiro M; Ohkubo K; Kato H; Kido Y; Anzai K; Oshima K; Ono J Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):319-24. PubMed ID: 12397529 [TBL] [Abstract][Full Text] [Related]
13. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study. Moosaie F; Firouzabadi FD; Abouhamzeh K; Esteghamati S; Meysamie A; Rabizadeh S; Nakhjavani M; Esteghamati A Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1723-1731. PubMed ID: 32636121 [TBL] [Abstract][Full Text] [Related]
14. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Rasouli M; Kiasari AM; Mokhberi V Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071 [TBL] [Abstract][Full Text] [Related]
15. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy. Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109 [TBL] [Abstract][Full Text] [Related]
16. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy. Mohan A; Saxena S; Kaur A; Ali W; Akduman L Mol Vis; 2021; 27():429-437. PubMed ID: 34267498 [TBL] [Abstract][Full Text] [Related]
17. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof]. Zhu H; Shi CH Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288 [TBL] [Abstract][Full Text] [Related]
18. Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study. Gao L; Zhang Y; Wang X; Dong H BMC Endocr Disord; 2021 Apr; 21(1):59. PubMed ID: 33794863 [TBL] [Abstract][Full Text] [Related]
19. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Sasongko MB; Wong TY; Nguyen TT; Kawasaki R; Jenkins A; Shaw J; Wang JJ Diabetes Care; 2011 Feb; 34(2):474-9. PubMed ID: 21270203 [TBL] [Abstract][Full Text] [Related]
20. Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus. Ding Y; Ge Q; Qu H; Feng Z; Long J; Wei Q; Zhou Q; Wu R; Yao L; Deng H J Endocrinol Invest; 2018 Aug; 41(8):937-945. PubMed ID: 29349642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]